174 related articles for article (PubMed ID: 14963066)
1. Diffusion of levofloxacin into bone and synovial tissues.
Rimmelé T; Boselli E; Breilh D; Djabarouti S; Bel JC; Guyot R; Saux MC; Allaouchiche B
J Antimicrob Chemother; 2004 Mar; 53(3):533-5. PubMed ID: 14963066
[TBL] [Abstract][Full Text] [Related]
2. Diffusion of ertapenem into bone and synovial tissues.
Boselli E; Breilh D; Djabarouti S; Bel JC; Saux MC; Allaouchiche B
J Antimicrob Chemother; 2007 Oct; 60(4):893-6. PubMed ID: 17704514
[TBL] [Abstract][Full Text] [Related]
3. Penetration of moxifloxacin and levofloxacin into cancellous and cortical bone in patients undergoing total hip arthroplasty.
Metallidis S; Topsis D; Nikolaidis J; Alexiadou E; Lazaraki G; Grovaris L; Theodoridou A; Nikolaidis P
J Chemother; 2007 Dec; 19(6):682-7. PubMed ID: 18230551
[TBL] [Abstract][Full Text] [Related]
4. Tissue and serum levofloxacin concentrations in diabetic foot infection patients.
Oberdorfer K; Swoboda S; Hamann A; Baertsch U; Kusterer K; Born B; Hoppe-Tichy T; Geiss HK; von Baum H
J Antimicrob Chemother; 2004 Oct; 54(4):836-9. PubMed ID: 15375105
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
Odenholt I; Cars O
J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
[TBL] [Abstract][Full Text] [Related]
6. Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients.
Deneke J; Luckow V; Guserle R; Pässler HH
Int J Clin Pharmacol Ther; 1998 Aug; 36(8):418-24. PubMed ID: 9726694
[TBL] [Abstract][Full Text] [Related]
7. Diffusion of isepamicin into cancellous and cortical bone tissue.
Boselli E; Breilh D; Bel JC; Debon R; Saux MC; Chassard D; Allaouchiche B
J Chemother; 2002 Aug; 14(4):361-5. PubMed ID: 12420853
[TBL] [Abstract][Full Text] [Related]
8. Penetration of piperacillin/tazobactam (4 g/500 mg) into synovial tissue.
Boselli E; Breilh D; Debon R; Duflo F; Bel JC; Saux MC; Chassard D; Allaouchiche B
J Chemother; 2002 Feb; 14(1):54-8. PubMed ID: 11892900
[TBL] [Abstract][Full Text] [Related]
9. Tissue pharmacokinetics of levofloxacin in human soft tissue infections.
Bellmann R; Kuchling G; Dehghanyar P; Zeitlinger M; Minar E; Mayer BX; Müller M; Joukhadar C
Br J Clin Pharmacol; 2004 May; 57(5):563-8. PubMed ID: 15089808
[TBL] [Abstract][Full Text] [Related]
10. Ceftriaxone bone penetration in patients with septic non-union of the tibia.
Garazzino S; Aprato A; Baietto L; D'Avolio A; Maiello A; De Rosa FG; Aloj D; Siccardi M; Biasibetti A; Massè A; Di Perri G
Int J Infect Dis; 2011 Jun; 15(6):e415-21. PubMed ID: 21497532
[TBL] [Abstract][Full Text] [Related]
11. Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease.
Conte JE; Golden JA; McIver M; Little E; Zurlinden E
Int J Antimicrob Agents; 2007 Nov; 30(5):422-7. PubMed ID: 17716873
[TBL] [Abstract][Full Text] [Related]
12. Penetration of levofloxacin into lung tissue after oral administration to subjects undergoing lung biopsy or lobectomy.
Lee LJ; Sha X; Gotfried MH; Howard JR; Dix RK; Fish DN
Pharmacotherapy; 1998; 18(1):35-41. PubMed ID: 9469679
[TBL] [Abstract][Full Text] [Related]
13. Concentrations in plasma, urinary excretion and bactericidal activity of levofloxacin (500 mg) versus ciprofloxacin (500 mg) in healthy volunteers receiving a single oral dose.
Wagenlehner FM; Kinzig-Schippers M; Sörgel F; Weidner W; Naber KG
Int J Antimicrob Agents; 2006 Dec; 28(6):551-9. PubMed ID: 17101261
[TBL] [Abstract][Full Text] [Related]
14. Diffusion of cefepime into cancellous and cortical bone tissue.
Breilh D; Boselli E; Bel JC; Chassard D; Saux MC; Allaouchiche B
J Chemother; 2003 Apr; 15(2):134-8. PubMed ID: 12797389
[TBL] [Abstract][Full Text] [Related]
15. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.
Conte JE; Golden JA; McIver M; Zurlinden E
Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169
[TBL] [Abstract][Full Text] [Related]
16. Liver tissue concentrations of levofloxacin after single intravenous administration of 500 mg for antibiotic prophylaxis in liver surgery.
Weinrich M; Scheingraber S; Stremovskaia T; Schilling MK; Kees F; Pistorius GA
Int J Antimicrob Agents; 2006 Sep; 28(3):221-5. PubMed ID: 16904875
[TBL] [Abstract][Full Text] [Related]
17. Levofloxacin pharmacokinetics in children.
Chien S; Wells TG; Blumer JL; Kearns GL; Bradley JS; Bocchini JA; Natarajan J; Maldonado S; Noel GJ
J Clin Pharmacol; 2005 Feb; 45(2):153-60. PubMed ID: 15647407
[TBL] [Abstract][Full Text] [Related]
18. Transfer of ciprofloxacin, ofloxacin and levofloxacin across the perfused human placenta in vitro.
Polachek H; Holcberg G; Sapir G; Tsadkin-Tamir M; Polachek J; Katz M; Ben-Zvi Z
Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):61-5. PubMed ID: 16154040
[TBL] [Abstract][Full Text] [Related]
19. Regional and systemic prophylaxis with teicoplanin in total knee arthroplasty: a tissue penetration study.
Lazzarini L; Novelli A; Marzano N; Timillero L; Fallani S; Viola R; de Lalla F
J Arthroplasty; 2003 Apr; 18(3):342-6. PubMed ID: 12728428
[TBL] [Abstract][Full Text] [Related]
20. [Bone diffusion of cefotiam in men].
Farinotti R; Vie P; Montes C; Cavagna R; Rosembaum M; Duparc J
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):638-42. PubMed ID: 2797889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
